Heart Failure in Brazil: How Can We Improve its Natural History?
Heart failure (HF) is a complex syndrome with high morbidity and mortality rates worldwide., Despite significant efforts, including several recent clinical trials involving tens of thousands of patients and various pharmacologic therapies,– reducing the burden of HF remains a challenge.
As of 2021, epidemiological data estimated that approximately 57 million people were affected by HF globally, and its prevalence is projected to rise by 34% in the coming decades. Patients hospitalized due to worsening HF are among the highest-risk groups, facing elevated rates of readmission and mortality, particularly during the vulnerable period shortly after discharge. The economic burden of HF is also significant; by 2030, HF-related costs in the U.S. are projected to exceed $70 billion annually.
[…]
Comments are moderated by the editorial team before publication. Discussions should be evidence-based and use scientific language. Conflicts of interest should be declared.